We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Effect of a Red Rice and Olive Extract Nutrition Supplement on Cholesterol Levels in Patients With Metabolic Syndrome

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT02065180
First Posted: February 17, 2014
Last Update Posted: May 20, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Veronique Verhoeven, Universiteit Antwerpen
  Purpose
This randomised controlled trial studies the effect of a commercially available nutritional supplement on cholesterol levels in people with metabolic syndrome and elevated cholesterol levels.

Condition Intervention Phase
Hypercholesterolaemia Dietary Supplement: commercially available nutrition supplement Dietary Supplement: placebo Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: The Effect of a Red Rice and Olive Extract Nutrition Supplement on Cholesterol

Resource links provided by NLM:


Further study details as provided by Veronique Verhoeven, Universiteit Antwerpen:

Primary Outcome Measures:
  • LDL level [ Time Frame: 2 months ]
  • total cholesterol level [ Time Frame: 2 months ]
  • triglyceride level [ Time Frame: 2 months ]
  • HDL level [ Time Frame: 2 months ]

Secondary Outcome Measures:
  • OxLDL [ Time Frame: 2 months ]
  • BMI [ Time Frame: 2 months ]
  • malondialdehyde (MDA) [ Time Frame: 2 months ]
  • 8-OH-deoxyguanosine (8-OHdG) [ Time Frame: 2 months ]
  • side effects [ Time Frame: 2 months ]
  • waist circumference [ Time Frame: 2 months ]

Enrollment: 50
Study Start Date: February 2014
Study Completion Date: May 2014
Primary Completion Date: May 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: commercially available nutrition supplement
this group receives a commercially available nutritional supplement for a period of 2 months
Dietary Supplement: commercially available nutrition supplement
the food supplement contains red rice yeast and olive extract
Placebo Comparator: control group
this group receives a placebo for a period of 2 months
Dietary Supplement: placebo

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • metabolic syndrome according to ATPIII criteria 3 of the following:

    • waist circumference >88cm (in females) or >102cm (in males)
    • triglycerides >150mg/dl
    • HDL <40 (50)mg/dl in males (females)
    • blood pressure>130/85 or treatment for AHT
    • glucose >110mg/dl

Exclusion Criteria:

  • pregnancy
  • treatment with cholesterol lowering drugs
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02065180


Locations
Belgium
University of Antwerp
Antwerp, Belgie, Belgium, 2610
Sponsors and Collaborators
Universiteit Antwerpen
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Veronique Verhoeven, Professor, Universiteit Antwerpen
ClinicalTrials.gov Identifier: NCT02065180     History of Changes
Other Study ID Numbers: verhoevenhermans
First Submitted: February 13, 2014
First Posted: February 17, 2014
Last Update Posted: May 20, 2014
Last Verified: May 2014

Additional relevant MeSH terms:
Hypercholesterolemia
Hyperlipidemias
Dyslipidemias
Lipid Metabolism Disorders
Metabolic Diseases